Intelligent sensors for quality-assured cell production

Fraunhofer experts are integrating real-time quality control in production – objective, automatable, and cost-efficient

05-Feb-2026 - Fraunhofer research scientists are optimizing the manufacturing of 3D tissue models using a modular sensor platform and AI. Their solution enables continuous quality control in bioreactors and opens up new perspectives for the biotech and pharmaceutical industries – for more than just animal-free ...

Automation makes personalized medicine affordable

Users benefit from cooperation between family business and start-up

19-Jan-2026 - It is not uncommon for the innovative strength of a start-up to be thwarted as soon as an investor steps in and imposes overly complex processes. In the cooperation between the family-owned company Bürkert Fluid Control Systems and Green Elephant Biotech (GEB), the specialists for sustainable ...

PL BioScience Announces Major Site Expansion

New 1,200 m² facility in Aachen expands headquarters to support company growth and scale Human Platelet Lysate production

04-Aug-2025 - PL BioScience GmbH, a German life science company specializing in the production and development of Human Platelet Lysate (HPL) for cell expansion, announced a significant expansion of company headquarters and future manufacturing capabilities to meet the rapidly growing global demand for safe, ...

PL BioScience and DewCell to jointly develop artificial human platelets for scalable cell culture media

"This collaboration is an important step on the way to replacing conventional products of animal origin"

21-May-2025 - PL BioScience GmbH, a German life science company specializing in the production and development of human platelet lysate (HPL) for cell expansion, announced the signing of a Letter of Intent (LOI) with Korean biotech company DewCell Biotherapeutics for the supply of artificial platelet raw ...

BioVaria 2025 honours Citrapeutics and Green Elephant Biotech with Startup Pitch & Partner Awards

05-May-2025 - A record number of over 320 innovators from the international life-science community gathered in Munich for the 17th BioVaria, Europe’s premier event for showcasing commercially attractive inventions and start-ups. A highlight was the BioVaria Startup Pitch & Partner Program, where 10 handpicked ...

Capricorn Scientific and florabio Join Forces to Revolutionize Animal-Free, High-Yield Cell Culture Media

22-Apr-2025 - Capricorn Scientific GmbH, a leading provider of sterile cell culture media and animal-free powders for the biotech and diagnostics industries, announces an innovative collaboration with florabio AS, led by the biotechnologist Dr. Aziz Cayli, who brings over 30 years of expertise in the field. ...

Bürkert invests in start-up Green Elephant Biotech

Working together for a sustainable future

17-Feb-2025 - Bürkert Fluid Control Systems has taken a stake in Green Elephant Biotech as a strategic investor so the two companies can work together to develop more efficient, flexible and sustainable cell cultivation processes in the pharmaceutical and biotech industries. This partnership should enable more ...

Evonik aligns two business lines with new growth strategy

Businesses outside core areas are to be sold or discontinued

16-Oct-2024 - Evonik is reorganizing two business lines to strengthen their growth prospects. Coating & Adhesive Resins and Health Care will focus on and concentrate future investments in their respective core businesses. The remaining businesses outside these cores are to be sold to new owners or incorporated ...

Animal-free cell therapy from Aachen secures global growth

PL BioScience closes Series A financing in the amount of 7.8 million euros

09-Aug-2024 - PL BioScience GmbH has successfully completed a Series A financing round. The growth financing round attracted significant investments from AVANT BIO (New York), LePure Biotech (Shanghai), b.value AG (Dortmund) and better ventures (Munich). The four partners contribute their experience in deep ...

Merck Invests More Than € 300 Million in New Life Science Research Center in Germany

Research center to accelerate biopharmaceutical product development

26-Apr-2024 - Merck, a leading science and technology company, is investing more than €300 million in a new research center at its global headquarters in Darmstadt, Germany. In the Advanced Research Center, the Life Science business sector will research solutions for manufacturing antibodies, mRNA ...